Zoli Matteo, Guaraldi Federica, Pasquini Ernesto, Frank Giorgio, Mazzatenta Diego
Center of Pituitary and Endoscopic Skull Base Surgery, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
J Neurol Surg B Skull Base. 2018 Oct;79(Suppl 4):S300-S310. doi: 10.1055/s-0038-1669463. Epub 2018 Aug 27.
The endoscopic endonasal approach (EEA) might seem an "unnatural" route for intradural lesions such as meningiomas. The aim of this study is to critically revise our management of anterior skull base meningiomas to consider, in what cases it may be advantageous. Each consecutive case of anterior skull base meningioma operated on through an EEA or combined endoscopic-transcranial approach at our institution, between 2003 and 2017, have been included. Tumors were classified on the basis of their location and intra or extracranial extension. Follow-up consisted of an MRI (magnetic resonance imaging) and a clinical examination 3 months after the surgery and then repeated annually. Fifty-seven patients were included. The most common location was the tuberculum sellae (62%), followed by olfactory groove (14%), planum sphenoidale (12%), and frontal sinus (12%). Among these, 65% were intracranial, 7% were extracranial, and 28% both intra and extracranial. Radical removal was achieved in 44 cases (77%). Complications consisted in 10 CSF (cerebrospinal fluid) leaks (17.6%), 1 overpacking (1.7%), and 1 asymptomatic brain ischemia (1.7%). Visual acuity and campimetric deficits improved respectively in 67 and 76% of patients. Recurrence rate was of 14%. EEA presents many advantages in selected cases of anterior skull base meningioma. However, it is hampered by the relevant risk of CSF leak. We consider that it could be advantageous for planum/tuberculum sellae tumors. Conversely, for olfactory groove or frontal sinus meningiomas, it can be indicated for tumors with extracranial extension, while its role is still debatable for purely intracranial forms as considering our surgical results, it could be advantageous for midline planum/tuberculum sellae tumors. Conversely, it can be of first choice for olfactory groove or frontal sinus meningiomas with extracranial extension, while its role for purely intracranial forms is still debatable.
对于诸如脑膜瘤等硬膜内病变,鼻内镜下经鼻入路(EEA)可能看似是一条“非自然”的路径。本研究的目的是审慎地审视我们对前颅底脑膜瘤的治疗方法,以考虑在哪些情况下它可能具有优势。纳入了2003年至2017年间在我们机构通过EEA或联合鼻内镜 - 经颅入路手术的每一例连续的前颅底脑膜瘤病例。肿瘤根据其位置以及颅内或颅外扩展情况进行分类。随访包括术后3个月的磁共振成像(MRI)和临床检查,然后每年重复进行。
共纳入57例患者。最常见的位置是鞍结节(62%),其次是嗅沟(14%)、蝶骨平台(12%)和额窦(12%)。其中,65%为颅内病变,7%为颅外病变,28%为颅内和颅外均有病变。44例(77%)实现了根治性切除。并发症包括10例脑脊液漏(17.6%)、1例过度填塞(1.7%)和1例无症状性脑缺血(1.7%)。67%和76%的患者视力和视野缺损分别得到改善。复发率为14%。
EEA在选定的前颅底脑膜瘤病例中具有许多优势。然而,它受到脑脊液漏相关风险的阻碍。我们认为对于蝶骨平台/鞍结节肿瘤可能是有利的。相反,对于嗅沟或额窦脑膜瘤,对于有颅外扩展的肿瘤可以采用该入路,而对于纯颅内形式的肿瘤,其作用仍有争议,因为从我们的手术结果来看,对于中线蝶骨平台/鞍结节肿瘤可能是有利的。相反,对于有颅外扩展的嗅沟或额窦脑膜瘤它可以是首选,而其对于纯颅内形式肿瘤的作用仍有争议。